• Mifepristone (RU486): Applied Workflows for Cancer and Ferti

  2026-05-26

  Mifepristone (RU486) is redefining experimental approaches in both oncology and reproductive biology thanks to its robust inhibition of progesterone receptor pathways. This article delivers actionable workflows, strategic troubleshooting, and insights from recent AR heterogeneity research, helping researchers optimize their assays with confidence.

• Vardenafil HCl Trihydrate: Precision Tool for PDE5 Assays

  2026-05-26

  Vardenafil HCl Trihydrate delivers unmatched selectivity and reproducibility in PDE5 inhibition and cGMP signaling studies. This article provides actionable workflows, protocol parameters, and troubleshooting guidance to help researchers maximize assay reliability and explore proteoform-specific interactions.

• Gly-Gly-Phe-Gly (GGFG): Precision Linker for Bioconjugation

  2026-05-25

  The GGFG peptide stands out as a flexible, high-purity linker for drug conjugation and antibody-drug conjugate (ADC) innovation. Streamline your bioconjugation workflows and troubleshoot with protocol-backed advice for reproducible, tunable results.

• Pravastatin Sodium (A4369): Reproducible Cholesterol Assays

  2026-05-25

  This article delivers evidence-based guidance for researchers using Pravastatin sodium (SKU A4369) to optimize cholesterol biosynthesis inhibition, LDL reduction, and cytotoxicity workflows. It bridges practical lab scenarios with validated protocol parameters and transparent product selection advice, ensuring experimental reproducibility and reliability in cell-based studies.

• Amikacin (BAY416651): Strategic Advances in Antibiotic Resis

  2026-05-24

  This article offers a mechanistic and translational deep dive into Amikacin (BAY416651), highlighting its distinct role in antibiotic resistance research. By weaving together molecular insights, targeted delivery strategies, and practical guidance for researchers, we present a forward-looking framework for deploying Amikacin in the study and management of multidrug-resistant bacterial infections.

• Calpain Inhibitor I, ALLN: Protocols and Technical Guidance

  2026-05-23

  Calpain Inhibitor I, ALLN (SKU A2602) is a potent, selective inhibitor of calpain and cathepsin proteases, primarily used in apoptosis assays and ischemia-reperfusion injury models. This reagent is best suited for mechanistic studies requiring precise protease inhibition, but is not intended for diagnostic or medical use, or workflows requiring water-soluble compounds.

• RNA Pol II Inhibition Triggers Active Apoptosis Independent

  2026-05-22

  Harper et al. (2025) reveal that cell death from RNA Pol II inhibition is not a passive consequence of transcriptional loss, but rather is driven by a regulated apoptotic pathway sensing loss of hypophosphorylated RNA Pol IIA. This finding reframes how transcriptional inhibitors act in cancer research, with implications for understanding drug lethality and apoptosis beyond gene expression changes.

• Nilotinib (AMN-107) in Cancer Research: Protocols & Innovati

  2026-05-22

  Nilotinib (AMN-107) empowers researchers to precisely dissect BCR-ABL and KIT-driven oncogenic signaling in both leukemia and GIST models. This guide translates cutting-edge in vitro methodology and troubleshooting tips into actionable workflows, ensuring robust experimental outcomes for chronic myeloid leukemia research and kinase inhibitor development.

• Hydroxytyrosol: Optimizing Antioxidant Workflows for Researc

  2026-05-21

  Hydroxytyrosol (4-(2-hydroxyethyl)benzene-1,2-diol) from APExBIO empowers oxidative stress, inflammation, and cardiovascular research with unmatched solubility and assay reliability. This guide translates new mechanistic findings into actionable protocols, troubleshooting tips, and advanced application strategies for bench scientists.

• Rosemary Extract Disrupts Renal Amyloid and Suppresses Apopt

  2026-05-21

  The referenced study demonstrates that rosemary ethanol extract (REE) can disrupt renal amyloid fibrils, restore cellular homeostasis, and suppress apoptosis in a mouse model of renal amyloidosis. These findings highlight the mechanistic complexity of RA and support the utility of early apoptosis detection tools in mechanistic renal research.

• EdU Imaging Kits (Cy5): Decoding Cell Proliferation and Mito

  2026-05-20

  Explore how EdU Imaging Kits (Cy5) enable precise S-phase DNA synthesis measurement in cardiomyocyte studies. This article delivers unique insight into mitochondrial injury mechanisms and advanced cell proliferation analysis, offering new perspectives beyond traditional assay strategies.

• Indazole/Indole Glucagon Receptor Antagonists: Innovation an

  2026-05-20

  This study introduces a novel series of indazole- and indole-based glucagon receptor antagonists, highlighting their synthesis, structure–activity relationship (SAR), and in vivo efficacy for glucose regulation. The findings inform rational design of potent glucagon receptor inhibitors with translational potential for type 2 diabetes research.

• A23187, Free Acid: Precision Control of Calcium Signaling in

  2026-05-19

  Discover how A23187, free acid—a leading calcium ionophore—enables advanced, reproducible control of intracellular Ca2+ levels in cell-based assays. This article delivers a novel perspective, integrating systems biology insights for researchers seeking rigorous experimental design.

• EdU Flow Cytometry Assay Kits (Cy5): Workflow Mastery & Inno

  2026-05-19

  The EdU Flow Cytometry Assay Kits (Cy5) unlock high-precision, multiplexable S-phase DNA synthesis detection without the harsh denaturation required by older BrdU methods. This article delivers actionable workflows, advanced troubleshooting, and insights into how the kit empowers translational research from wound healing to cancer biology.

• EdU Flow Cytometry Assay Kits (Cy5): Precision S-Phase Detec

  2026-05-18

  APExBIO’s EdU Flow Cytometry Assay Kits (Cy5) empower researchers to robustly quantify S-phase DNA synthesis with high sensitivity and streamlined workflows. Optimized for multiplexing and cell cycle analysis, the kit addresses longstanding limitations of BrdU-based assays and supports advanced applications in oncology, wound healing, and drug development.

576 records 10/39 page Previous Next First page 上5页 678910 下5页 Last page